Brief: Inify Laboratories Has Signed An Agreement With Region Jamtland Harjedalen For Prostate Cancer Diagnostics
24/04/2026 16:51
April 24 (Reuters) - INIFY Laboratories AB INIFY.OL: INIFY LABORATORIES HAS SIGNED AN AGREEMENT WITH REGION JÄMTLAND HÄRJEDALEN FOR PROSTATE CANCER DIAGNOSTICS INIFY LABORATORIES AB - AGREEMENT COVERS SPECIALISED PROSTATE CANCER DIAGNOSTICS TO REDUCE WAITING TIMES Source text: ID:nWkr1nxr5 Further company coverage: INIFY.OL ((Reuters.briefs@thomsonreuters.com;))
Recent news on INIFY Laboratories AB
See all newsBrief: Inify Laboratories Signs Deal With University Hospitals Plymouth NHS Trust
Brief: Inify Laboratories Gets CQC Registration, Is Fully Operational In UK
Brief: Inify Laboratories Q1 Sales Up At SEK 6.3 Mln
Brief: Inify Laboratories Signs Agreement With Region Jämtland Härjedalen
Brief: Inify Laboratories Has Signed An Agreement With Region Jamtland Harjedalen For Prostate Cancer Diagnostics